ConductScience.org, home

Paper20057930

Assessing the construct validity of aberrant salience.

Schmidt K and 1 other. Front Behav Neurosci, 2009. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Assessing the construct validity of aberrant salience. Papers, record 20057930. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20057930

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Assessing the construct validity of aberrant salience.
PubMed
Journal
Front Behav Neurosci
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2021-10-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schmidt KKristin
2Roiser JPJonathan P

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03754062Pharmacological Modulation of Belief SalienceResults

Source ClinicalTrials.gov

Download CSV of trials

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111955974Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses.Schizophr Res2002https://conductscience.org/library/papers/11955974PubMed
210550499Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour.Psychopharmacology (Berl)1999https://conductscience.org/library/papers/10550499PubMed
315817189Learned irrelevance is disrupted in first-episode but not chronic schizophrenia patients.Behav Brain Res2005https://conductscience.org/library/papers/15817189PubMed
411853979Psychotic symptoms in non-clinical populations and the continuum of psychosis.Schizophr Res2002https://conductscience.org/library/papers/11853979PubMed
519101122The relationship between interview-based schizotypal personality dimension scores and the continuous performance test.Schizophr Res2009https://conductscience.org/library/papers/19101122PubMed
612505794Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.Am J Psychiatry2003https://conductscience.org/library/papers/12505794PubMed
710727783Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events.Neuroscience2000https://conductscience.org/library/papers/10727783PubMed
89830253Are high-schizotypal normal participants distractible or limited in attentional resources? A study of latent inhibition as a function of masking task load and schizotypy level.J Abnorm Psychol1998https://conductscience.org/library/papers/9830253PubMed
91360261Loss of the Kamin blocking effect in acute but not chronic schizophrenics.Biol Psychiatry1992https://conductscience.org/library/papers/1360261PubMed
1015582114Disruption of learned irrelevance in acute schizophrenia in a novel continuous within-subject paradigm suitable for fMRI.Behav Brain Res2005https://conductscience.org/library/papers/15582114PubMed
1112396255Which schizotypal dimensions abolish latent inhibition?Br J Clin Psychol2002https://conductscience.org/library/papers/12396255PubMed
1218466609Incentive motivation in first-episode psychosis: a behavioural study.BMC Psychiatry2008https://conductscience.org/library/papers/18466609PubMed
139881538The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.J Clin Psychiatry1998https://conductscience.org/library/papers/9881538PubMed
149558Schizophrenic psychology, associative learning and the role of forebrain dopamine.Med Hypotheses1976https://conductscience.org/library/papers/9558PubMed
1518588739Do patients with schizophrenia exhibit aberrant salience?Psychol Med2009https://conductscience.org/library/papers/18588739PubMed
1610340292Delusions, superstitious conditioning and chaotic dopamine neurodynamics.Med Hypotheses1999https://conductscience.org/library/papers/10340292PubMed
1717684497Substantia nigra/ventral tegmental reward prediction error disruption in psychosis.Mol Psychiatry2008https://conductscience.org/library/papers/17684497PubMed
189858756What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?Brain Res Brain Res Rev1998https://conductscience.org/library/papers/9858756PubMed
1910689037Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.Neuropsychologia2000https://conductscience.org/library/papers/10689037PubMed
208353165Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: implications for schizophrenia.Biol Psychiatry1993https://conductscience.org/library/papers/8353165PubMed

See all 47 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
39268387How to elicit a negative bias? Manipulating contrast and saturation with the facial emotion salience task.Front Psychol2024https://conductscience.org/library/papers/39268387PubMed
38764742Overshadowing and salience attribution in relation to cannabis use.Schizophr Res Cogn2024https://conductscience.org/library/papers/38764742PubMed
35786401Aberrant salience correlates with psychotic dimensions in outpatients with schizophrenia spectrum disorders.Ann Gen Psychiatry2022https://conductscience.org/library/papers/35786401PubMed
34887781Cannabis Use, Schizotypy and Kamin Blocking Performance.Front Psychiatry2021https://conductscience.org/library/papers/34887781PubMed
31910256Cacna1c Hemizygosity Results in Aberrant Fear Conditioning to Neutral Stimuli.Schizophr Bull2020https://conductscience.org/library/papers/31910256PubMed
30096179Modeling subjective relevance in schizophrenia and its relation to aberrant salience.PLoS Comput Biol2018https://conductscience.org/library/papers/30096179PubMed
29691918The relationships among aberrant salience, reward motivation, and reward sensitivity.Int J Methods Psychiatr Res2018https://conductscience.org/library/papers/29691918PubMed
28740821Validating the construct of aberrant salience in schizophrenia - Behavioral evidence for an automatic process.Schizophr Res Cogn2016https://conductscience.org/library/papers/28740821PubMed
27628967Salience attribution and its relationship to cannabis-induced psychotic symptoms.Psychol Med2016https://conductscience.org/library/papers/27628967PubMed
27284531Are persistent delusions in schizophrenia associated with aberrant salience?Schizophr Res Cogn2016https://conductscience.org/library/papers/27284531PubMed
26194892Aberrant Salience Is Related to Dysfunctional Self-Referential Processing in Psychosis.Schizophr Bull2016https://conductscience.org/library/papers/26194892PubMed
26180188Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults.J Neurosci2015https://conductscience.org/library/papers/26180188PubMed
22089321The effect of dopamine agonists on adaptive and aberrant salience in Parkinson's disease.Neuropsychopharmacology2012https://conductscience.org/library/papers/22089321PubMed
21860047Integrative etiopathogenetic models of psychotic disorders: methods, evidence and concepts.Schizophr Bull2011https://conductscience.org/library/papers/21860047PubMed
20631686Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors.Neuropsychopharmacology2010https://conductscience.org/library/papers/20631686PubMed

Download CSV of cited by

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
LEVODOPACHEMBL1009Results1https://conductscience.org/library/drugs/CHEMBL1009ChEMBL
HALOPERIDOLCHEMBL54Results1https://conductscience.org/library/drugs/CHEMBL54ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20057930

GET https://conductscience.org/api/papers/v1/20057930/references?page=2